(Q44980719)

7 December 2017

Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study (English)

1 reference

7 December 2017

0 references

4

William W Busse

1 reference

7 December 2017

3

Jean Bousquet

1 reference

7 December 2017

Eric D Bateman

1

1 reference

7 December 2017

Homer A Boushey

2

1 reference

7 December 2017

Tim J H Clark

5

1 reference

7 December 2017

Romain A Pauwels

6

1 reference

7 December 2017

Søren E Pedersen

7

1 reference

7 December 2017

GOAL Investigators Group

8

1 reference

7 December 2017

language of work or name

English

0 references

publication date

15 July 2004

1 reference

American Journal of Respiratory and Critical Care Medicine

7 December 2017

1 reference

7 December 2017

170

1 reference

7 December 2017

836-844

1 reference

7 December 2017

8

1 reference

Asthma control in the Asia-Pacific region: the Asthma Insights and Reality in Asia-Pacific Study

7 December 2017

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200401-033OC

Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200401-033OC

Is overall asthma control being achieved? A hypothesis-generating study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200401-033OC

Achieving guideline-based asthma control: does the patient benefit?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200401-033OC

Anti-interleukin-5 (mepolizumab) therapy for hypereosinophilic syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200401-033OC

Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200401-033OC

Airway inflammation, basement membrane thickening and bronchial hyperresponsiveness in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200401-033OC

Optimal asthma control, starting with high doses of inhaled budesonide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200401-033OC

Cigarette smoking impairs the therapeutic response to oral corticosteroids in chronic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200401-033OC

Low dose inhaled budesonide and formoterol in mild persistent asthma: the OPTIMA randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200401-033OC

Control of asthma in Canada: failure to achieve guideline targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200401-033OC

Fluticasone propionate powder and lack of clinically significant effects on hypothalamic-pituitary-adrenal axis and bone mineral density over 2 years in adults with mild asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200401-033OC

10.1164/RCCM.200401-033OC

21 January 2018

Identifiers

DOI

1 reference

7 December 2017

1 reference